Moderna Inc. Announces New Vaccine that is 94.5% Effective in Preventing COVID-19

By  //  November 16, 2020

Share on Facebook Share on Twitter Share on LinkedIn Share on Delicious Digg This Stumble This

vaccine does not need ultra-cold storage like Pfizer vaccine

ABOVE VIDEO: Moderna CEO Stephane Bancel joins ‘Mornings with Maria’ to discuss the coronavirus vaccine breakthrough as it is said to be 94.5 percent effective.

(FOX BUSINESS) – Moderna Inc. said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to report results that far exceed expectations.

Together with Pfizer Inc’s vaccine, also shown to be more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available by the year’s end.

Next year, the U.S. government could have access to more than 1 billion doses just from the two vaccine makers, more than needed for the country’s 330 million residents.

The vaccines, both built using new technology known as messenger RNA or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million. The news also comes at time when COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.

CLICK HERE TO READ FULL ARTICLE ON FOX BUSINESS

CLICK HERE FOR BREVARD COUNTY NEWS

Leave a Comment